Robert Hermann
Research Subjects
Robert Hermann has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Mikael Knip
University of Helsinki
6 shared publications O. Simell
JDRF Centre for Prevention of Type 1 Diabetes in Finland
6 shared publicationsR. Veijola
JDRF Centre for Prevention of Type 1 Diabetes in Finland
5 shared publicationsJ. Ilonen
JDRF Centre for Prevention of Type 1 Diabetes in Finland
3 shared publications- Jorma Ilonen
Immunogenetics Laboratory, Institute of Biomedicine, University of Turku, Turku, Finland
3 shared publications H. K. Åkerblom
2 shared publications
Latest Publications
- Open Access
- 14 April 2006
- Published by Springer Nature in Diabetologia
- Vol. 49 (6) , 1198-1208
Lymphoid tyrosine phosphatase (LYP/PTPN22) Arg620Trp variant regulates insulin autoimmunity and progression to type 1 diabetes
We analysed the contribution of the lymphoid protein tyrosine phosphatase (LYP) Arg620Trp variant (which corresponds to the PTPN22 C1858T polymorphism) to the emergence of beta-cell-specific humoral autoimmunity and progression to type 1 diabetes in man. We also explored the heterogeneity in the disease-predisposing effect of this polymorphism in relation to known disease loci, sex and age at disease onset.
- 14 April 2006
- Published by Springer Nature in Diabetologia
- Vol. 49 (6) , 1198-1208
Open AccessLymphoid tyrosine phosphatase (LYP/PTPN22) Arg620Trp variant regulates insulin autoimmunity and progression to type 1 diabetes
We analysed the contribution of the lymphoid protein tyrosine phosphatase (LYP) Arg620Trp variant (which corresponds to the PTPN22 C1858T polymorphism) to the emergence of beta-cell-specific humoral autoimmunity and progression to type 1 diabetes in man. We also explored the heterogeneity in the disease-predisposing effect of this polymorphism in relation to known disease loci, sex and age at disease onset.
- 1 September 2005
- Published by American Diabetes Association in Diabetes
- Vol. 54 (9) , 2816-2819
Lack of Association of PAX4 Gene With Type 1 Diabetes in the Finnish and Hungarian Populations
We aimed to assess the possible contribution of the PAX4 transcription factor gene to the genetic background of type 1 diabetes. We analyzed four coding polymorphisms of the PAX4 gene in 498 cases with type 1 diabetes and 825 control subjects from Finland and Hungary. All patients were diagnosed under the age of 15 years according to the World Health Organization criteria. All four PAX4 variants (three in exon 9 and one in exon 3) were genotyped using DNA sequencing. In addition, all Finnish subjects were typed for HLA DR-DQ, insulin gene (−23) HphI, and CTLA4 CT60 polymorphisms. The +1,168 C/A coding variant of PAX4 was found to be polymorphic in both populations (P321H, rs712701). No difference was observed in the genotype frequencies between cases and control subjects, nor was any disease association detected when patients were stratified according to age at diagnosis, sex, HLA, insulin gene, or CTLA4 genotypes. Our data indicate that the +1,168 C/A variant of PAX4 gene does not play any essential role in genetic type 1 diabetes susceptibility. The strong coherence between the datasets of the two ethnic groups studied with highly contrasting disease incidence, socioeconomic characteristics, and profoundly diverse environment emphasizes the impact of this finding.
- 1 September 2005
- Published by American Diabetes Association in Diabetes
- Vol. 54 (9) , 2816-2819
Lack of Association of PAX4 Gene With Type 1 Diabetes in the Finnish and Hungarian Populations
We aimed to assess the possible contribution of the PAX4 transcription factor gene to the genetic background of type 1 diabetes. We analyzed four coding polymorphisms of the PAX4 gene in 498 cases with type 1 diabetes and 825 control subjects from Finland and Hungary. All patients were diagnosed under the age of 15 years according to the World Health Organization criteria. All four PAX4 variants (three in exon 9 and one in exon 3) were genotyped using DNA sequencing. In addition, all Finnish subjects were typed for HLA DR-DQ, insulin gene (−23) HphI, and CTLA4 CT60 polymorphisms. The +1,168 C/A coding variant of PAX4 was found to be polymorphic in both populations (P321H, rs712701). No difference was observed in the genotype frequencies between cases and control subjects, nor was any disease association detected when patients were stratified according to age at diagnosis, sex, HLA, insulin gene, or CTLA4 genotypes. Our data indicate that the +1,168 C/A variant of PAX4 gene does not play any essential role in genetic type 1 diabetes susceptibility. The strong coherence between the datasets of the two ethnic groups studied with highly contrasting disease incidence, socioeconomic characteristics, and profoundly diverse environment emphasizes the impact of this finding.
- 16 July 2005
- Published by Springer Nature in Diabetologia
- Vol. 48 (9) , 1766-1775
The effect of HLA class II, insulin and CTLA4 gene regions on the development of humoral beta cell autoimmunity
The aim of this study was to explore the contribution of genetic factors to the emergence of beta-cell-specific humoral autoimmunity.
- 16 July 2005
- Published by Springer Nature in Diabetologia
- Vol. 48 (9) , 1766-1775
The effect of HLA class II, insulin and CTLA4 gene regions on the development of humoral beta cell autoimmunity
The aim of this study was to explore the contribution of genetic factors to the emergence of beta-cell-specific humoral autoimmunity.
- 1 March 2004
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 20 (4) , 322-329
Genetic screening for individuals at high risk for type 1 diabetes in the general population using HLA Class II alleles as disease markers. A comparison between three European populations with variable rates of disease incidence
Background: To develop screening strategies for identification of individuals at increased genetic risk for type 1 diabetes in three populations with variable disease incidence rates and distinct ethnic origin.Methods: A stepwise HLA DQB1‐DQA1‐DRB1‐based screening approach was evaluated. Patients with childhood‐onset type 1 diabetes were recruited from Finland (n = 1739), Hungary (n = 149), and Greece (n = 119). Consecutive newborns (2568 from Finland and 1047 from Greece) or healthy schoolchildren (n = 177 from Hungary) served as controls.Results: The DQB1*02/0302 genotype conferred the highest disease risk in all populations. The DQB1*02/y (y ≠ DQB1*0301,*0302,*0602,*0603, *0604) genotypes were more common and conferred a higher disease risk in the Greek population (OR 4.9) compared to the Finns (OR 1.2). DQB1*0302/x (x ≠ DQB1*02, *0301, *0602, *0603, *0604) genotypes were, in contrast, more prevalent among Finnish cases (32.7%) as compared to Hungarians (18.1%) or Greeks (13.5%). The protective DQB1*0602 or *0603 positive genotypes were most common in the Finns, while DQB1*0301 was more common in Hungarians and Greeks. In all groups, DQA1 and DRB1*04 typing considerably increased the sensitivity of the DQB1‐based screening. The different high‐risk genotype combinations present in about 10% of the background population had a diagnostic sensitivity of 60% in Finland and 80% in Hungary and Greece.Conclusions: HLA DR‐DQ‐based screening is a feasible tool for the identification of individuals at increased genetic risk for type 1 diabetes in populations with diverse genetic background. The risk markers should, however, be individually selected for the target population since the screening efficiency of various markers is highly dependent on the ethnic group studied. Copyright © 2004 John Wiley & Sons, Ltd.
- 1 March 2004
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 20 (4) , 322-329
Genetic screening for individuals at high risk for type 1 diabetes in the general population using HLA Class II alleles as disease markers. A comparison between three European populations with variable rates of disease incidence
Background: To develop screening strategies for identification of individuals at increased genetic risk for type 1 diabetes in three populations with variable disease incidence rates and distinct ethnic origin.Methods: A stepwise HLA DQB1‐DQA1‐DRB1‐based screening approach was evaluated. Patients with childhood‐onset type 1 diabetes were recruited from Finland (n = 1739), Hungary (n = 149), and Greece (n = 119). Consecutive newborns (2568 from Finland and 1047 from Greece) or healthy schoolchildren (n = 177 from Hungary) served as controls.Results: The DQB1*02/0302 genotype conferred the highest disease risk in all populations. The DQB1*02/y (y ≠ DQB1*0301,*0302,*0602,*0603, *0604) genotypes were more common and conferred a higher disease risk in the Greek population (OR 4.9) compared to the Finns (OR 1.2). DQB1*0302/x (x ≠ DQB1*02, *0301, *0602, *0603, *0604) genotypes were, in contrast, more prevalent among Finnish cases (32.7%) as compared to Hungarians (18.1%) or Greeks (13.5%). The protective DQB1*0602 or *0603 positive genotypes were most common in the Finns, while DQB1*0301 was more common in Hungarians and Greeks. In all groups, DQA1 and DRB1*04 typing considerably increased the sensitivity of the DQB1‐based screening. The different high‐risk genotype combinations present in about 10% of the background population had a diagnostic sensitivity of 60% in Finland and 80% in Hungary and Greece.Conclusions: HLA DR‐DQ‐based screening is a feasible tool for the identification of individuals at increased genetic risk for type 1 diabetes in populations with diverse genetic background. The risk markers should, however, be individually selected for the target population since the screening efficiency of various markers is highly dependent on the ethnic group studied. Copyright © 2004 John Wiley & Sons, Ltd.
- 30 July 2003
- Published by Wiley in Tissue Antigens
- Vol. 62 (2) , 162-169
HLA DR‐DQ‐encoded genetic determinants of childhood‐onset type 1 diabetes in Finland: An analysis of 622 nuclear families
Abstract: The diabetes predisposing effect of HLA genes is defined by a complex interaction of various haplotypes. We analyzed the disease association of HLA DRB1‐DQA1‐DQB1 genotypes in a large nuclear family cohort (n = 622) collected in Finland. Using the affected family based artificial control approach we aimed at characterizing all detectable disease‐specific HLA haplotype and genotype effects. The DRB1*0401‐DQB1*0302 haplotype was the most prevalent disease susceptibility haplotype in the Finnish population followed by (DR3)‐DQA1*05‐DQB1*02 and DRB1*0404‐DQB1*0302. DRB1*0405‐DQB1*0302 conferred the highest disease risk, although this haplotype was very rare. The DRB1*04‐DQB1*0304 was also associated with increased disease risk, an effect detected for the first time in the Finnish population. The following haplotypes showed significant protection from the disease and are listed in decreasing order of the strength of their effect: (DR7)‐DQA1*0201‐DQB1*0303, (DR14)‐DQB1*0503, (DR15)‐DQB1*0602, DRB1*0403‐DQB1*0302, (DR13)‐DQB1*0603, (DR11/12/13)‐DQA1*05‐DQB1*0301, (DR1)‐DQB1*0501. In addition to the DRB1*0401/0404‐DQB1*0302/(DR3)‐DQA1*05‐DQB1*02 genotype and DRB1*04‐DQB1*0302 homozygous genotypes, heterozygous combinations DRB1*0401‐DQB1*0302/(DR13)‐DQB1*0604, ∼/(DR8)‐DQB1*04, ∼/(DR9)‐DQA1*03‐DQB1*0303, ∼/(DR1)‐DQB1*0501 and ∼/(DR7)‐DQA1*0201‐DQB1*02 were also disease‐associated. As a new finding in this population, the (DR3)‐DQA1*05‐DQB1*02 homozygous and (DR3)‐DQA1*05‐DQB1*02/(DR9)‐DQA1*03‐DQB1*0303 heterozygous genotypes conferred disease susceptibility. Similarly, the DRB1*0401‐DQB1*0302/(DR13)‐DQB1*0603 genotype was disease predisposing, implying that DQB*0603‐mediated protection from diabetes is not always dominant. Comparison of our findings with published data from other populations indicates a significant disease‐specific heterogeneity of the (DR8)‐DQB1*04, (DR7)‐DQA1*0201‐DQB1*02 and (DR3)‐DQA1*05‐DQB1*02 haplotypes.
- 30 July 2003
- Published by Wiley in Tissue Antigens
- Vol. 62 (2) , 162-169
HLA DR‐DQ‐encoded genetic determinants of childhood‐onset type 1 diabetes in Finland: An analysis of 622 nuclear families
Abstract: The diabetes predisposing effect of HLA genes is defined by a complex interaction of various haplotypes. We analyzed the disease association of HLA DRB1‐DQA1‐DQB1 genotypes in a large nuclear family cohort (n = 622) collected in Finland. Using the affected family based artificial control approach we aimed at characterizing all detectable disease‐specific HLA haplotype and genotype effects. The DRB1*0401‐DQB1*0302 haplotype was the most prevalent disease susceptibility haplotype in the Finnish population followed by (DR3)‐DQA1*05‐DQB1*02 and DRB1*0404‐DQB1*0302. DRB1*0405‐DQB1*0302 conferred the highest disease risk, although this haplotype was very rare. The DRB1*04‐DQB1*0304 was also associated with increased disease risk, an effect detected for the first time in the Finnish population. The following haplotypes showed significant protection from the disease and are listed in decreasing order of the strength of their effect: (DR7)‐DQA1*0201‐DQB1*0303, (DR14)‐DQB1*0503, (DR15)‐DQB1*0602, DRB1*0403‐DQB1*0302, (DR13)‐DQB1*0603, (DR11/12/13)‐DQA1*05‐DQB1*0301, (DR1)‐DQB1*0501. In addition to the DRB1*0401/0404‐DQB1*0302/(DR3)‐DQA1*05‐DQB1*02 genotype and DRB1*04‐DQB1*0302 homozygous genotypes, heterozygous combinations DRB1*0401‐DQB1*0302/(DR13)‐DQB1*0604, ∼/(DR8)‐DQB1*04, ∼/(DR9)‐DQA1*03‐DQB1*0303, ∼/(DR1)‐DQB1*0501 and ∼/(DR7)‐DQA1*0201‐DQB1*02 were also disease‐associated. As a new finding in this population, the (DR3)‐DQA1*05‐DQB1*02 homozygous and (DR3)‐DQA1*05‐DQB1*02/(DR9)‐DQA1*03‐DQB1*0303 heterozygous genotypes conferred disease susceptibility. Similarly, the DRB1*0401‐DQB1*0302/(DR13)‐DQB1*0603 genotype was disease predisposing, implying that DQB*0603‐mediated protection from diabetes is not always dominant. Comparison of our findings with published data from other populations indicates a significant disease‐specific heterogeneity of the (DR8)‐DQB1*04, (DR7)‐DQA1*0201‐DQB1*02 and (DR3)‐DQA1*05‐DQB1*02 haplotypes.
- 9 April 2003
- Published by Springer Nature in Diabetologia
- Vol. 46 (4) , 588-589
—to: Pani MA, Van Autreve J, Van Der Auwera BJ, Gorus FK, Badenhoop K (2002) Non-transmitted maternal HLA DQ2 or DQ8 alleles and risk of Type I diabetes in offspring: the importance of foetal or post partum exposure to diabetogenic molecules. Diabetologia 45:1340–1343
- 9 April 2003
- Published by Springer Nature in Diabetologia
- Vol. 46 (4) , 588-589
—to: Pani MA, Van Autreve J, Van Der Auwera BJ, Gorus FK, Badenhoop K (2002) Non-transmitted maternal HLA DQ2 or DQ8 alleles and risk of Type I diabetes in offspring: the importance of foetal or post partum exposure to diabetogenic molecules. Diabetologia 45:1340–1343
- 18 March 2003
- Published by Springer Nature in Diabetologia
- Vol. 46 (3) , 420-425
Temporal changes in the frequencies of HLA genotypes in patients with Type 1 diabetes—indication of an increased environmental pressure?
The incidence of Type 1 diabetes has increased 2.5 times during the time period from 1966 to 2000 in Finland—a general trend seen in almost all developed countries that can only be explained by environmental factors. The aim of this study was to test the possible effect of a changing environment on distribution of genotypes associated with disease susceptibility.
- 18 March 2003
- Published by Springer Nature in Diabetologia
- Vol. 46 (3) , 420-425
Temporal changes in the frequencies of HLA genotypes in patients with Type 1 diabetes—indication of an increased environmental pressure?
The incidence of Type 1 diabetes has increased 2.5 times during the time period from 1966 to 2000 in Finland—a general trend seen in almost all developed countries that can only be explained by environmental factors. The aim of this study was to test the possible effect of a changing environment on distribution of genotypes associated with disease susceptibility.
- 24 December 2002
- Published by Elsevier in Human Immunology
- Vol. 64 (1) , 152-155
Prevalence and HLA association of GAD65 antibodies in Hungarian schoolchildren.
- 24 December 2002
- Published by Elsevier in Human Immunology
- Vol. 64 (1) , 152-155
Prevalence and HLA association of GAD65 antibodies in Hungarian schoolchildren.